ALACHUA, Fla. and TAMPA, Fla., May 16, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, is ...
Q1 Non-GAAP EPS of -$0.06 beats by $0.01. Revenue of $41.4M (+12.8% Y/Y) misses by $0.65M. More on AxoGen AxoGen, Inc. (AXGN) ...
InvestingChannel on MSN10d
AxoGen, Inc. (NASDAQ:AXGN) Q1 2024 Earnings Call TranscriptMay 5, 2024 AxoGen, Inc. isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the ...
To get a sense of who is truly in control of AxoGen, Inc. ( NASDAQ:AXGN ), it is important to understand the ownership ...
ALACHUA, Fla. and TAMPA, Fla., May 14, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, ...
Tampa biotech company Axogen is on track to reach profitability this year for the first time since its founding two decades ago. CFO Nir Naor said the company expects to end the year with net positive ...
Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported financial results and business highlights for the ...
Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. It also provides products and education to improve surgical treatment ...
ALACHUA, Fla. (AP) — ALACHUA, Fla. (AP) — AxoGen Inc. (AXGN) on Thursday reported a loss of $6.6 million in its first quarter. The Alachua, Florida-based company said it had a loss of 15 cents ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback